Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

R1 RCM Appoints Gary Long as Chief Commercial Officer


Posted on: 02 Aug 17

CHICAGO, Aug. 02, 2017 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ:RCM), a leading provider of revenue cycle management and physician advisory services to healthcare providers, today announced the appointment of Gary Long to the newly created role of Executive Vice President and Chief Commercial Officer.

Long will be responsible for R1’s customer growth initiatives, including sales, marketing, product management and solution development. Long comes to R1 with more than 20 years of healthcare experience in leading organizations to drive revenue growth and profitability. Most recently, he was Senior Vice President and Chief Sales Officer at Premier Inc., where he developed and led a commercial organization focused on driving the company’s revenues across health systems, life sciences and government markets. Long created a professional and sustainable market-focused organization while leading the business up to and beyond its successful IPO in 2013.  Under Long’s leadership the business more than doubled its annual revenues while increasing its profitability. Prior to Premier, Long served as Senior Vice President of sales and support for Surgical Information Systems. Additionally, he previously worked at McKesson Corporation, where he held a series of progressive leadership roles in product management, corporate marketing and enterprise sales.

“I am very excited to join R1 and look forward to working with the team to drive the company’s growth. This is a pivotal time for healthcare providers as the industry must integrate and transform itself to provide higher quality and more cost-efficient care,” said Long.  “Healthcare financial leaders today need to transform their revenue cycle approach to address increasing complexity, shrinking margins and rising consumerism.  R1 is well positioned to partner with these leaders to improve the patient and provider experience while driving financial performance across the continuum of care.”  

“R1 has developed a comprehensive technology-enabled revenue cycle service platform and has optimized the performance of this platform in the past few years. As a direct result of the optimization of this platform, we are excited to enhance our commercialization efforts to drive sustainable growth for the company,” added Joe Flanagan, President and Chief Executive Officer of R1. “Gary’s background in revenue cycle management and track record in sales, marketing and product development positions him well to lead our commercial effort. We are delighted to welcome Gary to the R1 team.”

Long’s appointment is effective immediately and he will report directly to Joe Flanagan.

Forward-Looking Statements

This document includes information that may constitute “forward-looking statements,” made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements relate to future, not past, events and often address our expected future growth, plans and performance or forecasts. These forward-looking statements are often identified by the use of words such as “believe,” “designed,” “expect,” “plan,” “project,” “will,” or “would,” and similar expressions or variations, although not all forward-looking statements contain these identifying words. Such forward-looking statements are based on management’s current expectations about future events as of the date hereof and involve many risks and uncertainties that could cause our actual results to differ materially from those expressed or implied in our forward-looking statements. Subsequent events and developments, including actual results or changes in our assumptions, may cause our views to change. We do not undertake to update our forward-looking statements except to the extent required by applicable law.  Readers are cautioned not to place undue reliance on such forward-looking statements. All forward-looking statements included herein are expressly qualified in their entirety by these cautionary statements. Our actual results and outcomes could differ materially from those included in these forward-looking statements as a result of various factors, including, but not limited to: if we are not able to achieve or maintain profitability; if we are unable to retain our existing customers or acquire new customers; delayed or unsuccessful implementation of our technologies or services with our customers or implementation costs that exceed our expectations; as well as the factors discussed under the heading “Risk Factors” in our annual report on Form 10-K for the year ended December 31, 2016, our 2017 quarterly reports on Form 10-Q and any other periodic reports that the Company files with the Securities and Exchange Commission.

About R1 RCM
R1 serves as the one revenue cycle management partner for select hospitals and healthcare systems regardless of their payment models, patient engagement strategies, or settings of care.  The Company uses a proven operating model based on the R1 Performance StackSM designed to fit seamlessly into any healthcare organization’s infrastructure and to enhance the patient experience, improve provider economics, and provide revenue predictability. To learn more, visit r1rcm.com

GlobeNewswire
globenewswire.com

Last updated on: 02/08/2017

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.